BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29382514)

  • 1. [Epigenetic alterations in acute lymphoblastic leukemia].
    Navarrete-Meneses MDP; Pérez-Vera P
    Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics.
    Fathi E; Farahzadi R; Montazersaheb S; Bagheri Y
    Curr Gene Ther; 2021; 21(1):60-71. PubMed ID: 33183201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modulators of thyroid cancer.
    Rodríguez-Rodero S; Delgado-Álvarez E; Díaz-Naya L; Martín Nieto A; Menéndez Torre E
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):44-56. PubMed ID: 28440770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.
    San Jose-Eneriz E; Agirre X; Rodríguez-Otero P; Prosper F
    Epigenomics; 2013; 5(5):525-38. PubMed ID: 24059799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in pediatric acute lymphoblastic leukemia.
    Nordlund J; Syvänen AC
    Semin Cancer Biol; 2018 Aug; 51():129-138. PubMed ID: 28887175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Xu H; Yu H; Jin R; Wu X; Chen H
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of human retinoblastoma.
    Singh U; Malik MA; Goswami S; Shukla S; Kaur J
    Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis.
    Ranjbar R; Karimian A; Aghaie Fard A; Tourani M; Majidinia M; Jadidi-Niaragh F; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3216-3230. PubMed ID: 29384211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
    Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
    Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.
    Bartosch C; Lopes JM; Jerónimo C
    Epigenomics; 2017 Jun; 9(6):873-892. PubMed ID: 28523964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
    Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
    Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F
    Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia.
    Almamun M; Levinson BT; van Swaay AC; Johnson NT; McKay SD; Arthur GL; Davis JW; Taylor KH
    Epigenetics; 2015; 10(9):882-90. PubMed ID: 26308964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.